Compare FOR & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOR | AORT |
|---|---|---|
| Founded | 2005 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2007 | 1996 |
| Metric | FOR | AORT |
|---|---|---|
| Price | $25.11 | $22.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $34.00 | ★ $42.15 |
| AVG Volume (30 Days) | 158.2K | ★ 458.0K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $1,662,400,000.00 | $298,836,000.00 |
| Revenue This Year | N/A | $11.12 |
| Revenue Next Year | $1.20 | $10.77 |
| P/E Ratio | $15.77 | ★ N/A |
| Revenue Growth | 10.14 | ★ 18.01 |
| 52 Week Low | $22.81 | $19.16 |
| 52 Week High | $32.06 | $48.25 |
| Indicator | FOR | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 44.06 |
| Support Level | $24.04 | $21.76 |
| Resistance Level | $25.96 | $23.31 |
| Average True Range (ATR) | 0.75 | 0.88 |
| MACD | 0.04 | 0.14 |
| Stochastic Oscillator | 28.50 | 65.16 |
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.